Mesenchymal Cell News Volume 14.35 | Sep 6 2022

    0
    26








    2022-09-06 | MESCN 14.35


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 14.35 – 6 September, 2022
    TOP STORY

    Mesenchymal Stromal Cells Alleviate Acute Respiratory Distress Syndrome through the Cholinergic Anti-Inflammatory Pathway

    The authors hypothesized that the cholinergic anti-inflammatory pathway may be involved in the therapeutic mechanisms by which MSCs mitigate acute respiratory distress syndrome.
    [Signal Transduction and Targeted Therapy]

    Full Article
    Are Your Pluripotent Stem Cells What You Think They Are? Explore Now.
    PUBLICATIONSRanked by the impact factor of the journal

    A STAT5-Smad3 Dyad Regulates Adipogenic Plasticity of Visceral Adipose Mesenchymal Stromal Cells during Chronic Inflammation

    Using an adipogenic differentiation screen, researchers identified IFNγ and TGFβ as key inhibitors of primary human visceral adipose tissue-resident multipotent-MSC differentiation.
    [NPJ Regenerative Medicine]

    Full Article

    UHRF1 Overexpression Promotes Osteosarcoma Metastasis through Altered Exosome Production and AMPK/SEMA3E Suppression

    Investigators determined the role and regulatory mechanisms of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) in rendering osteosarcoma cells more aggressive.
    [Oncogenesis]

    Full Article

    β-Catenin Promotes Long-Term Survival and Angiogenesis of Peripheral Blood Mesenchymal Stem Cells via the Oct4 Signaling Pathway

    Scientists aimed to determine the roles of the β-catenin/Oct4 signaling axis in the regulation of long-term survival and angiogenesis of peripheral blood MSCs.
    [Experimental & Molecular Medicine]

    Full Article

    Knockdown of FOXA1 Enhances the Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells Partly via Activation of the ERK1/2 Signaling Pathway

    Researchers performed differential expression analysis of miRNAs between human bone MSCs and human dental pulp stem cells to identify osteogenic differentiation-related miRNAs.
    [Stem Cell Research & Therapy]

    Full Article

    Impact of Mesenchymal Stromal Cell-Derived Vesicular Cargo on B Cell Acute Lymphoblastic Leukemia Progression

    Investigators showed that bone marrow microenvironment (BMM)-deficiency of pleckstrin homology domain family M member 1 accelerated murine BCR-ABL1+ B-cell acute lymphoblastic leukemia via regulation of the cargo of small extracellular vesicles released by BMM-derived MSC.
    [Blood Advances]

    Abstract

    Differentiation of Equine Mesenchymal Stem Cells into Cells of Osteochondral Lineage: Potential for Osteochondral Tissue Engineering

    Scientists attempted to generate a zone of calcified cartilage using equine MSCs as the single source of cells and collagen as the scaffolding material.
    [Biomedical Materials]

    Abstract

    Sutureless Transplantation of In Vivo Priming Human Mesenchymal Stem Cell Sheet Promotes the Therapeutic Potential for Cardiac Repair

    Researchers demonstrated a novel way for a comprehensive cardiac repair achieved by the sutureless transplantation of highly integrable in vivo priming bone marrow MSC sheet based on the utilization of a highly aligned thermoresponsive nanofiber membrane.
    [Biofabrication]

    Abstract

    Glial Response to Intranasal Mesenchymal Stem Cells in Intermittent Cuprizone Model of Demyelination

    MSCs effectively homed to the corpus callosum area, were able to improve motor coordination, and to promote myelin recovery in the intermittent cuprizone.
    [Neurotoxicity Research]

    Abstract

    Microscopy images of pluripotent stem cells (PSCs) and PSC-derived cells for the #StemCellfie contest.
    REVIEWS

    The Dark Side of Adipose-Derived Mesenchymal Stromal Cells in Cutaneous Oncology: Roles, Expectations, and Potential Pitfalls.

    The authors summarize findings published on the use of adipose-derived stromal cells in the dermato-oncological setting, with the majority of data being available for melanoma.
    [Stem Cells and Development]

    Abstract
    INDUSTRY AND POLICY NEWS

    Immutep Announces Investigator-Initiated Phase II Trial Evaluating LAG-3 Candidate Eftilagimod Alpha (Efti) in Soft Tissue Sarcoma

    Immutep Limited announced it has signed a Material Transfer Agreement with the Maria Skłodowska-Curie National Research Institute of Oncology in Warsaw, Poland to enable an investigator-initiated open-label Phase II clinical trial.
    [Immutep Limited]

    Press Release
    FEATURED EVENT

    Skin Ageing & Challenges 2022

    November 17 – 18, 2022
    Lisbon, Portugal

    > See All Events

    JOB OPPORTUNITIES

    Associate Researcher – Translational Cancer Research

    Icahn School of Medicine at Mount Sinai – New York City, New York, United States

    Postdoctoral Fellowship – Metabolic Regulation of Early Human Development

    University of Copenhagen – Copenhagen, Denmark

    Research Technologist – Tissue and Cell Biology

    STEMCELL Technologies, Inc. – Vancouver, British Columbia, Canada

    Assistant Member – Genes and Human Disease Research Program

    Oklahoma Medical Research Foundation – Oklahoma City, Oklahoma, United States

    Faculty Member – Faculty of Life and Health Sciences

    Shenzhen Institute of Advanced Technology – Shenzhen, China

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter